Results 1 to 10 of about 29,434 (131)
International Journal of Pharmaceutical Sciences Review and Research, 2021 Pharmacovigilance started about 170 years ago, although it was not yet named as such at that time. It is structured activity in the professional health field, with important social and commercial implications aimed at monitoring the risk/benefit ratio of drugs, improving patient’s safety and the quality of life.
Adiba Nousheen +7 more
+7 more sources
A systematic review and pharmacovigilance analysis of the risk of agranulocytosis associated with metamizole use [PDF]
Scientific ReportsMetamizole is an analgesic widely used after its introduction but later withdrawn in several countries due to the risk of agranulocytosis. Despite this, it remains frequently used worldwide.
Alessia Zinzi +7 more
doaj +2 more sources
Organisation of the Russian Pharmacovigilance System: Survey of Pharmacovigilance Officers
Безопасность и риск фармакотерапии, 2021 Ensuring the safety of pharmacotherapy is a priority of the national regulatory health policy and is enshrined in the international and federal legislation.
A. E. Krasheninnikov +2 more
doaj +1 more source
International journal of health sciences, 2022 The World Health Organization (WHO) defines Pharmacovigilance as the science & activities relating to detection, assessment, understanding and prevention of adverse effects or any other drug related problem. The National Pharmacovigilance Programme (NPVP) was launched in 2004 with World Bank funding till 2009, which was renamed as Pharmacovigilance
Shruti Brahmbhatt, Mahavirsingh Rajput
openaire +1 more source
Frontiers in Immunology, 2023 BackgroundAlbeit the need for sex-disaggregated results of adverse events after immunization (AEFIs) is gaining attention since the COVID-19 pandemic, studies with emphasis on sexual dimorphism in response to COVID-19 vaccination are relatively scarce ...
Janneke W. Duijster +8 more
doaj +1 more source
Audits and inspections of pharmacovigilance systems in Russia
Качественная клиническая практика, 2023 The implementation of pharmacovigilance activities is impossible in isolation from compliance with the quality requirements of medicines and the activities of pharmaceutical and medical organizations throughout the pharmaceutical practice, as well as ...
A. A. Taube, B. K. Romanov
doaj +1 more source
Research Progress of Antitumor Pharmacovigilance
Chinese Journal of Lung Cancer, 2022 In 2019, Drug Administration Law of China was first time proposed that the country should establish pharmacovigilance system. In 2021, the first Pharmacovigilance Quality Management Standard of China was released.
Wenjuan SUN, Yang HU, Yan XU, Bo ZHANG
doaj +1 more source
BMC Infectious Diseases, 2021 Background Norovirus is an important cause of acute gastroenteritis globally. However, norovirus is rarely laboratory confirmed or recorded explicitly as a cause of hospitalization.
Elsa Negro-Calduch +2 more
doaj +1 more source
Evaluation of Pharmacovigilance System in Iran [PDF]
International Journal of Health Policy and Management, 2022 BackgroundEvaluating a pharmacovigilance system helps identify its deficiencies and could facilitate measures to remedy and improve the quantity and quality of adverse drug reaction (ADR) reports and other opportunities for pharmacovigilance systems ...
Malahat Khalili +6 more
doaj +1 more source
Suvorexant (Belsomra® Tablets 10, 15, and 20 mg): Japanese Drug-Use Results Survey
Drugs in R&D, 2018 Background We report on the results of a Japanese postmarketing drug-use survey of suvorexant (Belsomra®) tablets. Methods A survey with a ≤ 6-month observation period after the start of administration was conducted, targeting insomnia patients who were ...
Yuko Asai +5 more
doaj +1 more source